Antibody-drug conjugate shows efficacy against cell surface protein in neuroblastoma
CHOP researchers: This first-in-class immunotherapeutic approach could spawn new treatment options for neuroblastoma and other high-mortality childhood cancersCredit: Children's Hospital ...









